Skip to main content
. 2019 Mar 26;16(3):784–796. doi: 10.1007/s13311-019-00726-3

Fig. 5.

Fig. 5

Effects of Suvorexant on sleep in 3.5-month-old male R6/1 and WT littermates. Sleep-onset latencies to first SWS (a) and REM sleep (b) episodes following Suvorexant treatment. Percentage of durations (c) and number of episodes (d) of sleep and waking during inactive light and active dark periods following treatment. Data are presented as median ± min-max range in a and b and mean ± SEM in c and d. *p < .05, ** p < .01, #p = .07